What Comes After Ozempic? A Chattanooga Physician on Amycretin

I am Dr. Paul Miranda, a board-certified physician at Summit Metabolic Health. I read every patient chart myself, and part of my job is separating genuine scientific progress from headlines. Amycretin (its emerging drug name is zenagamtide) is real progress — but it is also years from a pharmacy shelf, and understanding why it works tells you more about good weight-loss care than the number on any press release.

Amycretin: Two Appetite Signals in One Molecule

Today’s GLP-1 medications act mainly on one hormone pathway that governs appetite and blood sugar. Amycretin is different in an elegant way: it is a single molecule engineered to hit two receptors at once — the GLP-1 receptor and the amylin receptor. Amylin is a second satiety hormone that works through a different part of the brain than GLP-1 does (Gasiorek A et al, Lancet 2025; PMID 40550229). Two non-overlapping “full” signals instead of one is the whole idea — and Novo is developing it in both a once-weekly injection and a once-daily pill.

That is a genuinely different approach from stacking two separate drugs together. Amycretin builds both jobs into one peptide, so the two effects rise and fall on the same schedule. It is the clearest example yet of where obesity medicine is heading: not just stronger versions of one lever, but medications that pull on several biological levers at once.

Why the Early Numbers Turned Heads

In an early-phase injectable study, the highest dose of amycretin was associated with about 24.3 percent average body-weight reduction at 36 weeks, versus about 1.1 percent on placebo (Dahl K et al, Lancet 2025; PMID 40550231). The oral version, in a separate early study, produced up to about 13.1 percent at just 12 weeks versus 1.2 percent on placebo (PMID 40550229). A 2026 comparison of trials ranked high-dose injectable amycretin first among the newer agents for weight loss (network meta-analysis, PMID 42175595). Those are striking figures — but they come with heavy caveats, and I want to be honest about them.

What This Means for a Patient in Chattanooga Today

Here is the part the headlines skip. Amycretin is investigational. It is not FDA-approved for anything, it cannot be prescribed, and its large confirmatory trials are still recruiting — a realistic approval is somewhere around the end of this decade. So the practical answer to “should I wait for amycretin?” is no. Waiting years to start improving your metabolic health is almost never the right trade.

But amycretin still teaches a lesson you can act on right now. Its whole premise — that pulling on more than one biological lever beats leaning hard on a single one — is exactly how I already practice. The medication is one lever. The others are protein intake high enough to protect muscle, resistance training, sleep, and reading the metabolic labs that tell us what your body is actually doing. That combination is available in Tennessee today. Amycretin just proves the strategy is right.

What I Do for Patients at Summit Now

At Summit Metabolic Health I do not chase whichever molecule is trending. I use the proven, FDA-approved medications we have — and I wrap them in the same multi-lever thinking that makes the frontier drugs exciting.

This is where a physician-led program and a telehealth refill mill genuinely diverge. A questionnaire scored by software prescribes a dose and moves on. It does not read your labs, protect your muscle, or plan for the day you come off the medication. That thinking is the entire point of metabolic medicine — and it is why I read every chart at Summit myself.

And because Summit builds an exit strategy into every plan — get you to your goal weight, then taper the medication in a controlled way — the goal is durable results, not a prescription you rent forever. It is also the program designed to get cheaper as you get healthier.

The Bottom Line for Chattanooga

Amycretin is a genuinely interesting glimpse of where weight-loss medicine is going — two appetite signals in one molecule, in both a pill and an injection. But it is investigational, years away, and no reason to postpone your own progress. The smartest move for someone in Tennessee right now is to start with a physician who already treats obesity the way the frontier drugs are designed to — from several angles at once, with an actual doctor reading the chart.

You can apply in about five minutes at summitmetabolichealth.com/apply. I personally review every application and reach out — no algorithms, no sales calls.